What question did this study set out to answer?

The research aims to discover and optimize new kinase inhibitors for better effectiveness and safety.

April 13, 2026Open Access

Discovery of potent kinase inhibitors with improved pharmacokinetics and safety potentials through structural optimization of dasatinib

Key Points

The research aims to discover and optimize new kinase inhibitors for better effectiveness and safety.
Structural optimization of dasatinib to enhance its inhibitory effects.
Evaluation of pharmacokinetics to assess absorption and metabolism.
Assessment of safety profiles in preclinical models.
PDD-87 identified as a highly potent kinase inhibitor.
Significant improvements observed in pharmacokinetics compared to dasatinib.
Enhanced safety potentials indicate broader clinical applicability.

Abstract

PDD-87 is a highly potent, selective kinase inhibitor with improved pharmacokinetics and safety potentials, holding promise for broader clinical applications.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

He et al. (Fri,) studied this question.

synapsesocial.com/papers/69dc87983afacbeac03e9d1b https://doi.org/https://doi.org/10.1038/s43856-026-01550-5

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI से पूछें

Bookmark

View Full Paper